Panacea Biotec Ltd

NSE :PANACEABIO   BSE :531349  Sector : Pharmaceuticals
Buy, Sell or Hold PANACEABIO? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

25 Apr
146.50
(3.21%)
24 Apr
141.95
(2.79%)
23 Apr
138.10
(0.07%)
22 Apr
138.00
(1.17%)
19 Apr
136.40
(-0.76%)
18 Apr
137.45
(-1.04%)
16 Apr
138.90
(1.05%)
15 Apr
137.45
(-4.68%)
12 Apr
144.20
(-1.23%)
10 Apr
146.00
(1.07%)
09 Apr
144.45
(1.05%)
08 Apr
142.95
(-1.58%)
05 Apr
145.25
(1.33%)
04 Apr
143.35
(3.46%)
03 Apr
138.55
(2.44%)
02 Apr
135.25
(2.27%)
01 Apr
132.25
(8.80%)
28 Mar
121.55
(-1.58%)
27 Mar
123.50
(-2.29%)
26 Mar
126.40
(-5.18%)
22 Mar
133.30
(-0.89%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish
Medium Term Investors

Neutral
Long Term Investors

Bearish

Moving Averages

5 DMA
Bullish

140.17

10 DMA
Bullish

140.53

20 DMA
Bullish

137.95

50 DMA
Bullish

144.09

100 DMA
Bearish

157.01

200 DMA
Bearish

151.36


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Apr 25, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 159.9 154.9 149.03 - -
R2 154.9 151.39 148.19 155.1 -
R1 150.7 149.21 147.34 151.1 152.8
P 145.7 145.7 145.7 145.9 146.75
S1 141.5 142.19 145.66 141.9 143.6
S2 136.5 140.01 144.81 136.7 -
S3 132.3 136.5 143.97 - -

Key Metrics

EPS

0

P/E

0

P/B

2.71

Dividend Yield

0%

Market Cap

897 Cr.

Face Value

1

Book Value

53.9

ROE

-11.06%

EBITDA Growth

7.31 Cr.

Debt/Equity

0.03

Shareholding Pattern

  73.59% Total Promoter Holding
0% Mutual Fund Holdings
0.27% FIIs
25.3% Non Institution
0% Insurance Companies
0% Custodians
0.84% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Panacea Biotec Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 156.91 163.37 163.01 149.02 158.96
PROFIT -5.33 -1.17 -14.71 -10.88 -4.36
EPS 3.16 -2.07 1.79 -1.35 -0.37

Panacea Biotec Ltd Quaterly Results


Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
INCOME 81.68 85.29 92.75 96.72 98.28
PROFIT 13.24 -19.69 1.29 3.2 0.43
EPS 2.16 -3.21 0.21 0.52 0.07

Profit & Loss (Figures in Rs. Crores)


Panacea Biotec Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 713.13 700.81 700.9 607.49 611.51 758.16 607.3 629.25 2397.38 579.9
PROFIT -277.97 -105.96 -66.53 -62.36 -73.98 -288.05 -159.82 -147.66 -197 -94.64
EPS 0 0 0 0 0 5.64 -29.1 -24.11 176.05 -5.51

Panacea Biotec Ltd Profit & Loss


Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
INCOME 822.58 680.86 700.6 601.1 271.48 400.59 217.15 350.07 309.02 260.36
PROFIT -288.51 -65.1 -48.78 -34.74 -71.88 -276.22 -121.7 -17.7 -93.59 -92.84
EPS 0 0 0.13 0 0 3.98 -22.93 -2.36 -15.28 -14.29

Balance Sheet (Figures in Rs. Crores)

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 6.136.136.136.136.136.136.1322.4322.436.13
Reserves Total 815.82848.86-256.47138.87334.63292.91339.91426.18448.76506.59
Equity Share Warrants00032000000
Equity Application Money21.6521.6521.6521.799.649.649.6400.10
Total Shareholders Funds843.6876.64-228.69198.79350.4308.68355.68448.61471.29512.72
Minority Interest-3.49-2.98-3-3.04-3.01-2.9510.541.083.425.48
Secured Loans 0.240.29759.5708.64604.57906.96959.871,058.161,059.431,014.89
Unsecured Loans 19.9833.8760.0333.5541.9333.7933.7130.2735.4544.85
Total Debt20.2234.16819.53742.19646.5940.75993.581,088.431,094.881,059.74
Other Liabilities58.6974.74225.05129.4843.7530.83120.6462.3426.2814.64
Total Liabilities919.02982.56812.891,067.421,037.641,277.311,480.441,600.461,595.871,592.58
APPLICATION OF FUNDS :
Gross Block 1,330.831,317.481,261.621,274.641,392.91,605.841,600.071,620.291,633.481,697.62
Less: Accumulated Depreciation730.88695.41652.92617.25587.34656.87598.7549.18489.18422.08
Net Block599.95622.07608.7657.39805.56948.971,001.371,071.111,144.31,275.54
Capital Work in Progress42.3217.2634.4224.0122.5139.9330.41160.95155.48172.48
Investments 13.495.070.075.585.337.287.288.7115.1815.97
Inventories 202.09212.72174.14147.6981.43334.21315.55305.24310.22219.81
Sundry Debtors 60.0981.6684.6868.5288.73136.01142.17141.6798.5794.93
Cash and Bank Balance225.99583.28135.7989.7523.4823.2414.1322.9352.424.78
Loans and Advances 60.7367.9116.36377.31314.2564.8761.3176.0259.5533.29
Total Current Assets548.9945.56510.97683.27507.89558.32533.17545.86520.74372.81
Current Liabilities 295.07740.28351.27315.48323.97314.04299.8251.94327.91348.12
Provisions 36.736.0313.377.4113.926.958.811.516.212.13
Total Current Liabilities & Provisions331.77776.32364.65322.89337.89320.99308.61253.45334.12350.25
Net Current Assets217.13169.24146.32360.38170237.33224.56292.41186.6222.56
Deferred Tax Assets79.89127.44120.28135.63167.22219.22246.784.0389.1193.76
Deferred Tax Liability100.26103.69120.13133.68147.43208.82228.2984.5389.5994.28
Net Deferred Tax-20.3723.750.151.9519.7910.418.41-0.5-0.48-0.52
Other Assets66.5145.1623.2318.1114.4533.4198.4167.7894.77106.55
Total Assets919.03982.55812.891,067.411,037.641,277.311,480.441,600.461,595.871,592.58
Contingent Liabilities639.76368.17406.99366.93404.06378.64364.27353.54353.535.15
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
SOURCES OF FUNDS :
Share Capital 6.136.136.136.136.1315.596.1322.4322.436.13
Reserves Total 297.87387.32480.39832.82402.71372.33440.06517.6517.28556.16
Equity Share Warrants00032000000
Equity Application Money21.6521.6521.6521.799.649.649.64000
Total Shareholders Funds325.65415.1508.17892.74418.48397.56455.83540.03539.71562.29
Secured Loans 0.240.295.0512.44604.57906.96959.87962.38955.95911.85
Unsecured Loans 102.2283.8760.0354.884.1153.2762.6556.7158.8178.58
Total Debt102.4684.1665.0867.24688.68960.231,022.521,019.091,014.76990.43
Other Liabilities18.1115.8820.5217.9714.1729.4221.9714.5212.3813.36
Total Liabilities446.22515.14593.77977.951,121.331,387.211,500.321,573.641,566.851,566.08
APPLICATION OF FUNDS :
Gross Block 909.49907.86893.02905.42813.951,542.551,536.971,518.161,532.121,493.54
Less : Accumulated Depreciation 474.13453.83428.77406.14317.52651.62594.95530.58472.44407.59
Net Block 435.36454.03464.25499.28496.43890.93942.02987.581,059.681,085.95
Capital Work in Progress27.850.8812.973.743.137.1627.6819.0116.9826.08
Investments 0.270.270.272.552.54344.88344.88394.66394.66394.2
Inventories 116.1129.2587.0499.2342.51149.1140.6136.57140.9176.76
Sundry Debtors 12.2723.3235.2917.6925.2142.27175.8142.21100.4390.58
Cash and Bank Balance43.2542.6988.9660.617.8511.797.219.3242.379.68
Loans and Advances 27.5253.5781.26436.8840.5550.580.0853.0131.4714.09
Total Current Assets199.14248.82292.55614.32916.1353.65403.7341.11315.17291.11
Current Liabilities 224.16217.84192.08157.44311.05279.5279.99232.42307.23318.48
Provisions 28.7428.864.443.19.666.791.451.375.151.9
Total Current Liabilities & Provisions252.89246.7196.52160.54320.72286.29281.45233.79312.38320.38
Net Current Assets-53.762.1296.03453.77595.3967.36122.25107.322.79-29.27
Deferred Tax Assets46.0272.090135.13166.64203.13234.6384.0389.1193.88
Deferred Tax Liability70.8272.090133.68147.43181.14202.7684.0389.1193.88
Net Deferred Tax-24.8001.4519.2121.9931.87000
Other Assets61.357.8320.2517.164.6524.8931.6165.0792.7489.12
Total Assets446.21515.13593.77977.951,121.331,387.211,500.311,573.641,566.851,566.08
Contingent Liabilities639.76368.17406.99366.93404.06378.64364.27353.54353.535.15

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...12.81
Depreciation39.12
Interest (Net)-7.12
P/L on Sales of Assets-5.29
P/L on Sales of Invest-1.95
Prov. and W/O (Net)-22.06
P/L in Forex3.53
Total Adjustments (PBT and Ext...-95.87
Operating Profit before Workin...-83.06
Trade and 0ther Receivables6.89
Inventories10.63
Loans and Advances-30.79
Total Adjustments (OP before W...-336.91
Cash Generated from/(used in) ...-419.98
Direct Taxes Paid-2.48
Total Adjustments(Cash Generat...-2.48
Cash Flow before Extraordinary...-422.45
Net Cash from Operating Activi...-422.45
Purchased of Fixed Assets-40.95
Sale of Fixed Assets39.51
Purchase of Investments-211.69
Sale of Investments205.18
Interest Received11.56
Net Cash used in Investing Act...430.33
Of the Long Tem Borrowings-14.77
Interest Paid-3.6
Net Cash used in Financing Act...-18.37
Net Profit before Tax and Extr...-62.75
Depreciation24.5
Interest (Net)7.83
P/L on Sales of Assets-5.24
Prov. and W/O (Net)-21.82
P/L in Forex4.6
Total Adjustments (PBT and Ext...10.43
Operating Profit before Workin...-52.32
Trade and 0ther Receivables-4.02
Inventories13.15
Loans and Advances-3.99
Total Adjustments (OP before W...42.67
Cash Generated from/(used in) ...-9.66
Direct Taxes Paid-1.09
Total Adjustments(Cash Generat...-1.09
Cash Flow before Extraordinary...-10.74
Net Cash from Operating Activi...-10.74
Purchased of Fixed Assets-38.38
Sale of Fixed Assets39.43
Interest Received2.23
Net Cash used in Investing Act...2.41
Proceed from 0ther Long Term B...146.45
Of the Long Tem Borrowings-128.99
Interest Paid-8.45
Net Cash used in Financing Act...9.01

Company Details

Registered Office
AddressAmbala-Chandigarh Highway,
CityLalru
StatePunjab
Pin Code140501
Tel. No.91-1762-505900
Fax. No.
Emailcorporate@panaceabiotec.com; investorgrievances@pa
Internethttp://www.panaceabiotec.com
Registrars
AddressAmbala-Chandigarh Highway
CityLalru
StatePunjab
Pin Code140501
Tel. No.91-1762-505900
Fax. No.
Emailcorporate@panaceabiotec.com; investorgrievances@pa
Internethttp://www.panaceabiotec.com
Management
Name Designation
Rajesh JainChairman & Managing Director
Sandeep JainJoint Managing Director
R L NarasimhanNon-Exec. & Independent Dir.
N N KhamitkarNon-Exec. & Independent Dir.
K M LalNon-Exec. & Independent Dir.
Vinod GoelGroup CFO & Company Secretary
Manjula UpadhyayNon-Exec. & Independent Dir.
Mukul GuptaNon-Exec. & Independent Dir.
Ankesh JainWhole-time Director
BHUPINDER SINGHNon-Exec. & Independent Dir.
Narotam Kumar JunejaNon Executive Director